Vaxart, Inc. Gains 33.33%
Tue 21 Apr 20 at 05:30 PM
Vaxart, Inc. (VXRT:NASDAQ) rocketted at $3.16, representing a gain of 33.3%. On Mon 20 Apr 20, VXRT:NASDAQ touched a New 2-Week High of $2.37. The stock got featured on our News Catalysts scanner on Tue 21 Apr 20 at 11:57 AM in the 'BIOTECH' category. From Mon 06 Apr 20, the stock recorded 55.56% Up Days and 80.00% Green Days
The stock spiked on Fri 28 Feb 20 at $3.5 with a volume of 29M+.
About Vaxart, Inc. (VXRT:NASDAQ)
Aviragen Therapeutics Inc is a bio-pharmaceutical company. It is engaged in developing direct-acting antivirals to treat infections that affect a number of patients. It includes oral, small molecule compounds to treat infectious diseases.
Top 10 Gainers:
- Energous Corporation (WATT:NASDAQ), 155.98%
- Gulfport Energy Corporation (GPOR:NASDAQ), 82.69%
- SandRidge Energy, Inc. (SD:NYSE), 69.44%
- TORM plc (TRMD:NASDAQ), 65.79%
- SilverBow Resources, Inc. (SBOW:NYSE), 42.86%
- Huitao Technology Co., Ltd. (HHT:NASDAQ), 41.46%
- NanoViricides, Inc. (NNVC:NYSEMKT), 33.62%
- Vaxart, Inc. (VXRT:NASDAQ), 33.33%
- The Peck Company Holdings, Inc. (PECK:NASDAQ), 31.09%
- Integrated Media Technology Limited (IMTE:NASDAQ), 29.34%